56
Participants
Start Date
February 5, 2021
Primary Completion Date
November 30, 2026
Study Completion Date
November 30, 2027
FLT imaging and TK1 blood measurements
F18 labeled thymidine PET/CT scans will be performed. Serum measurements of TK1 will be obtained.
RECRUITING
Emory University, Atlanta
NOT_YET_RECRUITING
University Hospital of Cleveland UH Seidman Cancer Center, Cleveland
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City
Emory University
OTHER
University of Michigan
OTHER
University Hospitals Cleveland Medical Center
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Oklahoma
OTHER